Associated Papers
Association of Rare Variants in ARSA with Parkinson's Disease.
Senkevich K et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2023
Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix.
Trinidad M et al.
Genome Biology, 2023
37480112 (PubMed )
Supplement: 13059_2023_3001_MOESM1_ESM.xlsx › Table_S1
From Lysosomal Storage Disorders to Parkinson's Disease - Challenges and Opportunities.
Mächtel R et al.
Journal of Molecular Biology, 2023
Association of rare variants in ARSA with Parkinson's disease.
Senkevich K et al.
Medrxiv : the Preprint Server for Health Sciences, 2023
Exploiting the Potential of Drosophila Models in Lysosomal Storage Disorders: Pathological Mechanisms and Drug Discovery.
Rigon L et al.
Biomedicines, 2021
Arylsulfatase A (ASA) in Parkinson's Disease: From Pathogenesis to Biomarker Potential.
Angelopoulou E et al.
Brain Sciences, 2020
Genetic analysis of arylsulfatase A (ARSA) in Chinese patients with Parkinson's disease.
Ruan Y et al.
Neuroscience Letters, 2020
Chaperones and Proteostasis: Role in Parkinson's Disease.
Joshi N et al.
Diseases (basel, Switzerland), 2020
ARSA gene variants and Parkinson's disease.
Fan Y et al.
Brain : a Journal of Neurology, 2020
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease.
Paciotti S et al.
Journal of Clinical Medicine, 2020
ARSA variants in α-synucleinopathies.
Makarious MB et al.
Brain : a Journal of Neurology, 2019
Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.
Lee JS et al.
Brain : a Journal of Neurology, 2019
Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy.
Cesani M et al.
Human Mutation, 2016
Late infantile metachromatic leukodystrophy: Clinical manifestations of five Taiwanese patients and Genetic features in Asia.
Liaw HR et al.
Orphanet Journal of Rare Diseases, 2015
Select a paper to view details